Cuba vs Nicaragua: HIV-positive TB patients on ART (antiretroviral therapy)
Cuba
100.0%
in 2024
Nicaragua
100.0%
in 2023
Cuba rank
1st
Nicaragua rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cuba
- Nicaragua
How they compare
Cuba currently reports 100.0% against 100.0% in Nicaragua, a difference of 0.0%.
The two have swapped places 6 times across 14 shared years of data; in 2008 it was Nicaragua ahead.
Cuba ranks 1st and Nicaragua ranks 1st of 144 countries.
Across the 3 decades both report, Cuba averaged higher in 2 and Nicaragua in 1.
Head to head by decade
| Decade | Cuba | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.5% | 97.0% | 48.5% | Nicaragua |
| 2010s | 90.9% | 87.4% | 3.5% | Cuba |
| 2020s | 98.8% | 98.2% | 0.5% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cuba or Nicaragua?
- Cuba, at 100.0% against 100.0% in Nicaragua as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cuba and Nicaragua?
- 0.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Nicaragua?
- 14 years are reported by both, from 2008 to 2023.
- How do Cuba and Nicaragua rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cuba ranks 1st and Nicaragua ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.